Home Effect of collection matrix, platelet depletion, and storage conditions on plasma extracellular vesicles and extracellular vesicle-associated miRNAs measurements
Article
Licensed
Unlicensed Requires Authentication

Effect of collection matrix, platelet depletion, and storage conditions on plasma extracellular vesicles and extracellular vesicle-associated miRNAs measurements

  • Martina Faraldi ORCID logo , Marta Gomarasca ORCID logo , Silvia Perego ORCID logo EMAIL logo , Veronica Sansoni ORCID logo , Giuseppe Banfi ORCID logo and Giovanni Lombardi ORCID logo
Published/Copyright: November 30, 2020
Become an author with De Gruyter Brill
Submit Manuscript Author Information
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Clinical Chemistry and Laboratory Medicine (CCLM) Volume 59 Issue 5

Abstract

Objectives

The interest around circulating extracellular vesicles and their cargo in diagnostics has greatly increased; however, several pre-analytical variables affect their determination. In this study, we investigated the effects of sample matrix, processing, and plasma storage delay and temperature on extracellular vesicles and their miRNA content.

Methods

Blood was collected from 10 male volunteers in dipotassium ethylendiaminotetraacetate-coated tubes (K2EDTA), either with plasma-preparation tube (PPT) or without (K2E) gel separator. A stepwise centrifugation was applied to K2E aliquots to obtain platelet-poor plasma (PPP). K2E, PPP and PPT plasma, stored under different conditions, were assayed for extracellular vesicles concentration and size distribution, through dynamic laser light scattering, and microRNAs content, by qPCR.

Results

PPP samples were characterized by the lowest extracellular vesicles count and miRNA detectability. Although having no effects on extracellular vesicles total concentration, storage conditions influenced microRNAs detectability, mainly in PPP and PPT samples. Extracellular vesicles-associated miRNAs levels in K2E were, in general, higher than in PPP and to a very limited extent to PPT. Storage temperature and delay did not affect their profile in K2E samples.

Conclusions

Extracellular vesicles count and extracellular vesicles miRNA profile changed under the analyzed pre-analytical variables, showing the greatest stability in K2E samples. Since pre-analytical variables differently affected extracellular vesicles and their miRNA content, they should be considered in each experimental setting and clinical routine.

Keywords: circulating microRNA; extracellular vesicles; plasma; pre-analytical variable
Corresponding author: Silvia Perego, Ph.D., Laboratory of Experimental Biochemistry & Molecular Biology, IRCCS Istituto Ortopedico Galeazzi, Via Riccardo Galeazzi, 4 – 20161, Milan, Italy, Phone: +39 0266214068, E-mail:

Funding source: Italian Ministry of Health

Acknowledgments

The authors are grateful to Prof. Giberto Chirico and Prof. Maddalena Collini (Department of Physics, National Institute of Nuclear Physics, Università degli Studi di Milano-Bicocca) for their help in designing, conducting and interpreting the DLS experiments.

  1. Research funding: This work has been funded by the Italian Ministry of Health.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: Research involving human subjects complied with all relevant national regulations, institutional policies and is in accordance with the tenets of the Helsinki Declaration (as revised in 2013), and has been approved by Comitato Etico Ospedale San Raffaele, Milano, Italia (SportMarker, ClinicalTrials.gov registration number NCT03386981).

References

1. Bonini, P, Plebani, M, Ceriotti, F, Rubboli, F. Errors in laboratory medicine. Clin Chem 2002;48:691–8. https://doi.org/10.1093/clinchem/48.5.691.Search in Google Scholar

2. Lippi, G, Chance, JJ, Church, S, Dazzi, P, Fontana, R, Giavarina, D, et al.. Preanalytical quality improvement: from dream to reality. Clin Chem Lab Med 2011;49:1113–26. https://doi.org/10.1515/cclm.2011.600.Search in Google Scholar PubMed

3. Dugue, B, Lombardi, G, Banfi, G. What everybody should know about postural changes. Scand J Clin Lab Invest 2018;78:407–10. https://doi.org/10.1080/00365513.2018.1473634.Search in Google Scholar PubMed

4. Lombardi, G, Barbaro, M, Locatelli, M, Banfi, G. Novel bone metabolism-associated hormones: the importance of the pre-analytical phase for understanding their physiological roles. Endocrine 2017;56:460–84. https://doi.org/10.1007/s12020-017-1239-z.Search in Google Scholar PubMed

5. Cheng, HH, Yi, HS, Kim, Y, Kroh, EM, Chien, JW, Eaton, KD, et al.. Plasma processing conditions substantially influence circulating microRNA biomarker levels. PloS One 2013;8:e64795. https://doi.org/10.1371/journal.pone.0064795.Search in Google Scholar PubMed PubMed Central

6. Zhao, H, Shen, J, Hu, Q, Davis, W, Medico, L, Wang, D, et al.. Effects of preanalytic variables on circulating microRNAs in whole blood. Canc Epidemiol Biomarkers Prev 2014;23:2643–8. https://doi.org/10.1158/1055-9965.epi-14-0550.Search in Google Scholar

7. Glinge, C, Clauss, S, Boddum, K, Jabbari, R, Jabbari, J, Risgaard, B, et al.. Stability of circulating blood-based MicroRNAs - pre-analytic methodological considerations. PloS One 2017;12:e0167969. https://doi.org/10.1371/journal.pone.0167969.Search in Google Scholar PubMed PubMed Central

8. Faraldi, M, Sansoni, V, Perego, S, Gomarasca, M, Kortas, J, Ziemann, E, et al.. Study of the preanalytical variables affecting the measurement of clinically relevant free-circulating microRNAs: focus on sample matrix, platelet depletion, and storage conditions. Biochem Med 2020;30:010703. https://doi.org/10.11613/bm.2020.010703.Search in Google Scholar

9. Ha, M, Kim, VN. Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol 2014;15:509–24. https://doi.org/10.1038/nrm3838.Search in Google Scholar PubMed

10. Li, Y, Kowdley, KV. MicroRNAs in common human diseases. Dev Reprod Biol 2012;10:246–53. https://doi.org/10.1016/j.gpb.2012.07.005.Search in Google Scholar PubMed PubMed Central

11. Ludwig, N, Leidinger, P, Becker, K, Backes, C, Fehlmann, T, Pallasch, C, et al.. Distribution of miRNA expression across human tissues. Nucleic Acids Res 2016;44:3865–77. https://doi.org/10.1093/nar/gkw116.Search in Google Scholar PubMed PubMed Central

12. Weber, JA, Baxter, DH, Zhang, S, Huang, DY, Huang, KH, Lee, MJ, et al.. The microRNA spectrum in 12 body fluids. Clin Chem 2010;56:1733–41. https://doi.org/10.1373/clinchem.2010.147405.Search in Google Scholar PubMed PubMed Central

13. Turchinovich, A, Weiz, L, Langheinz, A, Burwinkel, B. Characterization of extracellular circulating microRNA. Nucleic Acids Res 2011;39:7223–33. https://doi.org/10.1093/nar/gkr254.Search in Google Scholar PubMed PubMed Central

14. O’Brien, J, Hayder, H, Zayed, Y, Peng, C. Overview of microRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol 2018;9:402. https://doi.org/10.3389/fendo.2018.00402.Search in Google Scholar PubMed PubMed Central

15. Turchinovich, A, Weiz, L, Burwinkel, B. Extracellular miRNAs: the mystery of their origin and function. Trends Biochem Sci 2012;37:460–5. https://doi.org/10.1016/j.tibs.2012.08.003.Search in Google Scholar PubMed

16. Zhao, C, Sun, X, Li, L. Biogenesis and function of extracellular miRNAs. ExRNA 2019;1:38. https://doi.org/10.1186/s41544-019-0039-4.Search in Google Scholar

17. Gyorgy, B, Szabo, TG, Pasztoi, M, Pal, Z, Misjak, P, Aradi, B, et al.. Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci 2011;68:2667–88. https://doi.org/10.1007/s00018-011-0689-3.Search in Google Scholar PubMed PubMed Central

18. Shah, R, Patel, T, Freedman, JE. Circulating extracellular vesicles in human disease. N Engl J Med 2018;379:958–66. https://doi.org/10.1056/nejmra1704286.Search in Google Scholar PubMed

19. Becker, A, Thakur, BK, Weiss, JM, Kim, HS, Peinado, H, Lyden, D. Extracellular vesicles in cancer: cell-to-cell mediators of metastasis. Canc Cell 2016;30:836–48. https://doi.org/10.1016/j.ccell.2016.10.009.Search in Google Scholar PubMed PubMed Central

20. Gomarasca, M, Maroni, P, Banfi, G, Lombardi, G. microRNAs in the antitumor immune response and in bone metastasis of breast cancer: from biological mechanisms to therapeutics. Int J Mol Sci 2020;21:2805. https://doi.org/10.3390/ijms21082805.Search in Google Scholar PubMed PubMed Central

21. Bottani, M, Banfi, G, Lombardi, G. Circulating miRNAs as diagnostic and prognostic biomarkers in common solid tumors: focus on lung, breast, prostate cancers, and osteosarcoma. J Clin Med 2019;8:1661. https://doi.org/10.3390/jcm8101661.Search in Google Scholar PubMed PubMed Central

22. Bottani, M, Banfi, G, Lombardi, G. The clinical potential of circulating miRNAs as biomarkers: present and future applications for diagnosis and prognosis of age-associated bone diseases. Biomolecules 2020;10:589. https://doi.org/10.3390/biom10040589.Search in Google Scholar PubMed PubMed Central

23. Mateescu, B, Kowal, EJ, van Balkom, BW, Bartel, S, Bhattacharyya, SN, Buzas, EI, et al.. Obstacles and opportunities in the functional analysis of extracellular vesicle RNA – an ISEV position paper. J Extracell Vesicles 2017;6:1286095. https://doi.org/10.1080/20013078.2017.1286095.Search in Google Scholar PubMed PubMed Central

24. Lacroix, R, Judicone, C, Poncelet, P, Robert, S, Arnaud, L, Sampol, J, et al.. Impact of pre-analytical parameters on the measurement of circulating microparticles: towards standardization of protocol. J Thromb Haemostasis 2012;10:437–46. https://doi.org/10.1111/j.1538-7836.2011.04610.x.Search in Google Scholar PubMed

25. Ramirez, MI, Amorim, MG, Gadelha, C, Milic, I, Welsh, JA, Freitas, VM, et al.. Technical challenges of working with extracellular vesicles. Nanoscale 2018;10:881–906. https://doi.org/10.1039/c7nr08360b.Search in Google Scholar PubMed

26. Witwer, KW, Buzas, EI, Bemis, LT, Bora, A, Lasser, C, Lotvall, J, et al.. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles 2013;2:20360. https://doi.org/10.3402/jev.v2i0.20360.Search in Google Scholar PubMed PubMed Central

27. Lacroix, R, Judicone, C, Mooberry, M, Boucekine, M, Key, NS, Dignat-George, F, et al.. Standardization of pre-analytical variables in plasma microparticle determination: results of the International Society on Thrombosis and Haemostasis SSC Collaborative Workshop. J Thromb Haemostasis 2013 Sep 3. https://doi.org/10.1093/gji/ggv269 [Epub ahead of print].Search in Google Scholar

28. Zampetaki, A, Mayr, M. Analytical challenges and technical limitations in assessing circulating miRNAs. Thromb Haemostasis 2012;108:592–8. https://doi.org/10.1160/TH12-02-0097.Search in Google Scholar PubMed

29. Armand-Labit, V, Pradines, A. Circulating cell-free microRNAs as clinical cancer biomarkers. Biomol Concepts 2017;8:61–81. https://doi.org/10.1515/bmc-2017-0002.Search in Google Scholar PubMed

30. Sapp, RM, Shill, DD, Roth, SM, Hagberg, JM. Circulating microRNAs in acute and chronic exercise: more than mere biomarkers. J Appl Physiol 2017;122:702–17. https://doi.org/10.1152/japplphysiol.00982.2016.Search in Google Scholar PubMed

31. Silva, GJJ, Bye, A, El Azzouzi, H, Wisloff, U. MicroRNAs as important regulators of exercise adaptation. Prog Cardiovasc Dis 2017;60:130–51. https://doi.org/10.1016/j.pcad.2017.06.003.Search in Google Scholar PubMed

32. Sansoni, V, Perego, S, Vernillo, G, Barbuti, A, Merati, G, La Torre, A, et al.. Effects of repeated sprints training on fracture risk-associated miRNA. Oncotarget 2018;9:18029–40. https://doi.org/10.18632/oncotarget.24707.Search in Google Scholar PubMed PubMed Central

33. Sturgeon, C, Hill, R, Hortin, GL, Thompson, D. Taking a new biomarker into routine use--a perspective from the routine clinical biochemistry laboratory. Proteonomics Clin Appl 2010;4:892–903. https://doi.org/10.1002/prca.201000073.Search in Google Scholar PubMed PubMed Central

34. Coumans, FAW, Brisson, AR, Buzas, EI, Dignat-George, F, Drees, EEE, El-Andaloussi, S, et al.. Methodological guidelines to study extracellular vesicles. Circ Res 2017;120:1632–48. https://doi.org/10.1161/circresaha.117.309417.Search in Google Scholar

35. Thery, C, Witwer, KW, Aikawa, E, Alcaraz, MJ, Anderson, JD, Andriantsitohaina, R, et al.. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles 2018;7:1535750. https://doi.org/10.1080/20013078.2018.1461450.Search in Google Scholar

36. Fendl, B, Weiss, R, Fischer, MB, Spittler, A, Weber, V. Characterization of extracellular vesicles in whole blood: influence of pre-analytical parameters and visualization of vesicle-cell interactions using imaging flow cytometry. Biochem Biophys Res Commun 2016;478:168–73. https://doi.org/10.1016/j.bbrc.2016.07.073.Search in Google Scholar PubMed

37. Vila-Liante, V, Sanchez-Lopez, V, Martinez-Sales, V, Ramon-Nunez, LA, Arellano-Orden, E, Cano-Ruiz, A, et al.. Impact of sample processing on the measurement of circulating microparticles: storage and centrifugation parameters. Clin Chem Lab Med 2016;54:1759–67. https://doi.org/10.1515/cclm-2016-0036.Search in Google Scholar PubMed

38. Jayachandran, M, Miller, VM, Heit, JA, Owen, WG. Methodology for isolation, identification and characterization of microvesicles in peripheral blood. J Immunol Methods 2012;375:207–14. https://doi.org/10.1016/j.jim.2011.10.012.Search in Google Scholar PubMed PubMed Central

39. Wisgrill, L, Lamm, C, Hartmann, J, Preissing, F, Dragosits, K, Bee, A, et al.. Peripheral blood microvesicles secretion is influenced by storage time, temperature, and anticoagulants. Cytometry 2016;89:663–72. https://doi.org/10.1002/cyto.a.22892.Search in Google Scholar PubMed

40. Ge, Q, Zhou, Y, Lu, J, Bai, Y, Xie, X, Lu, Z. miRNA in plasma exosome is stable under different storage conditions. Molecules 2014;19:1568–75. https://doi.org/10.3390/molecules19021568.Search in Google Scholar PubMed PubMed Central

Supplementary Material

The online version of this article offers supplementary material (https://doi.org/10.1515/cclm-2020-1296).

Received: 2020-08-25
Accepted: 2020-11-17
Published Online: 2020-11-30
Published in Print: 2021-04-27

© 2020 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Home pregnancy tests: quality first
  4. Review
  5. Non-invasive determination of uric acid in human saliva in the diagnosis of serious disorders
  6. Opinion Papers
  7. Basophil counting in hematology analyzers: time to discontinue?
  8. The role of laboratory hematology between technology and professionalism: the paradigm of basophil counting
  9. Recommendations for validation testing of home pregnancy tests (HPTs) in Europe
  10. General Clinical Chemistry and Laboratory Medicine
  11. The use of preanalytical quality indicators: a Turkish preliminary survey study
  12. The Italian External Quality Assessment (EQA) program on urinary sediment by microscopy examination: a 20 years journey
  13. Non-HDL-C/TG ratio indicates significant underestimation of calculated low-density lipoprotein cholesterol (LDL-C) better than TG level: a study on the reliability of mathematical formulas used for LDL-C estimation
  14. Evaluation of the protein gap for detection of abnormal serum gammaglobulin level: an imperfect predictor
  15. Impact of routine S100B protein assay on CT scan use in children with mild traumatic brain injury
  16. Using machine learning to develop an autoverification system in a clinical biochemistry laboratory
  17. Effect of collection matrix, platelet depletion, and storage conditions on plasma extracellular vesicles and extracellular vesicle-associated miRNAs measurements
  18. Pneumatic tube transportation of urine samples
  19. Evaluation of the first immunosuppressive drug assay available on a fully automated LC-MS/MS-based clinical analyzer suggests a new era in laboratory medicine
  20. A validated LC-MS/MS method for the simultaneous quantification of the novel combination antibiotic, ceftolozane–tazobactam, in plasma (total and unbound), CSF, urine and renal replacement therapy effluent: application to pilot pharmacokinetic studies
  21. Immunosuppressant quantification in intravenous microdialysate – towards novel quasi-continuous therapeutic drug monitoring in transplanted patients
  22. Reference Values and Biological Variations
  23. Reference intervals for venous blood gas measurement in adults
  24. Cardiovascular Diseases
  25. Detection and functional characterization of a novel MEF2A variation responsible for familial dilated cardiomyopathy
  26. Diabetes
  27. Evaluation of the ARKRAY HA-8190V instrument for HbA1c
  28. Infectious Diseases
  29. An original multiplex method to assess five different SARS-CoV-2 antibodies
  30. Evaluation of dried blood spots as alternative sampling material for serological detection of anti-SARS-CoV-2 antibodies using established ELISAs
  31. Variability of cycle threshold values in an external quality assessment scheme for detection of the SARS-CoV-2 virus genome by RT-PCR
  32. The vasoactive peptide MR-pro-adrenomedullin in COVID-19 patients: an observational study
  33. Corrigenda
  34. Corrigendum to: Understanding and managing interferences in clinical laboratory assays: the role of laboratory professionals
  35. Corrigendum to: Age appropriate reference intervals for eight kidney function and injury markers in infants, children and adolescents
  36. Letters to the Editor
  37. A panhaemocytometric approach to COVID-19: a retrospective study on the importance of monocyte and neutrophil population data on Sysmex XN-series analysers
  38. Letter in reply to the letter to the editor of Harte JV and Mykytiv V with the title “A panhaemocytometric approach to COVID-19: a retrospective study on the importance of monocyte and neutrophil population data”
  39. SARS-CoV-2 serologic tests: do not forget the good laboratory practice
  40. Long-term kinetics of anti-SARS-CoV-2 antibodies in a cohort of 197 hospitalized and non-hospitalized COVID-19 patients
  41. Self-sampling at home using volumetric absorptive microsampling: coupling analytical evaluation to volunteers’ perception in the context of a large scale study
  42. Vortex mixing to alleviate pseudothrombocytopenia in a blood specimen with platelet satellitism and platelet clumps
  43. Comparative evaluation of the fully automated HemosIL® AcuStar ADAMTS13 activity assay vs. ELISA: possible interference by autoantibodies different from anti ADAMTS-13
  44. Significant interference on specific point-of-care glucose measurements due to high dose of intravenous vitamin C therapy in critically ill patients
  45. As time goes by, on that you can rely … preservation of urine samples for morphological analysis of erythrocytes and casts
  46. Stability of control materials for α-thalassemia immunochromatographic strip test
  47. Reformulated Architect® cyclosporine CMIA assay: improved imprecision, worse comparability between methods
  48. Urine-to-plasma contamination mimicking acute kidney injury: small drops with major consequences
  49. Automated Mindray CL-1200i chemiluminescent assays of renin and aldosterone for the diagnosis of primary aldosteronism
  50. Use of common reference intervals does not necessarily allow inter-method numerical result trending
  51. Reply to Dr Hawkins regarding comparability of results for monitoring
https://doi.org/10.1515/cclm-2020-1296
Keywords for this article
circulating microRNA; extracellular vesicles; plasma; pre-analytical variable

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Home pregnancy tests: quality first
  4. Review
  5. Non-invasive determination of uric acid in human saliva in the diagnosis of serious disorders
  6. Opinion Papers
  7. Basophil counting in hematology analyzers: time to discontinue?
  8. The role of laboratory hematology between technology and professionalism: the paradigm of basophil counting
  9. Recommendations for validation testing of home pregnancy tests (HPTs) in Europe
  10. General Clinical Chemistry and Laboratory Medicine
  11. The use of preanalytical quality indicators: a Turkish preliminary survey study
  12. The Italian External Quality Assessment (EQA) program on urinary sediment by microscopy examination: a 20 years journey
  13. Non-HDL-C/TG ratio indicates significant underestimation of calculated low-density lipoprotein cholesterol (LDL-C) better than TG level: a study on the reliability of mathematical formulas used for LDL-C estimation
  14. Evaluation of the protein gap for detection of abnormal serum gammaglobulin level: an imperfect predictor
  15. Impact of routine S100B protein assay on CT scan use in children with mild traumatic brain injury
  16. Using machine learning to develop an autoverification system in a clinical biochemistry laboratory
  17. Effect of collection matrix, platelet depletion, and storage conditions on plasma extracellular vesicles and extracellular vesicle-associated miRNAs measurements
  18. Pneumatic tube transportation of urine samples
  19. Evaluation of the first immunosuppressive drug assay available on a fully automated LC-MS/MS-based clinical analyzer suggests a new era in laboratory medicine
  20. A validated LC-MS/MS method for the simultaneous quantification of the novel combination antibiotic, ceftolozane–tazobactam, in plasma (total and unbound), CSF, urine and renal replacement therapy effluent: application to pilot pharmacokinetic studies
  21. Immunosuppressant quantification in intravenous microdialysate – towards novel quasi-continuous therapeutic drug monitoring in transplanted patients
  22. Reference Values and Biological Variations
  23. Reference intervals for venous blood gas measurement in adults
  24. Cardiovascular Diseases
  25. Detection and functional characterization of a novel MEF2A variation responsible for familial dilated cardiomyopathy
  26. Diabetes
  27. Evaluation of the ARKRAY HA-8190V instrument for HbA1c
  28. Infectious Diseases
  29. An original multiplex method to assess five different SARS-CoV-2 antibodies
  30. Evaluation of dried blood spots as alternative sampling material for serological detection of anti-SARS-CoV-2 antibodies using established ELISAs
  31. Variability of cycle threshold values in an external quality assessment scheme for detection of the SARS-CoV-2 virus genome by RT-PCR
  32. The vasoactive peptide MR-pro-adrenomedullin in COVID-19 patients: an observational study
  33. Corrigenda
  34. Corrigendum to: Understanding and managing interferences in clinical laboratory assays: the role of laboratory professionals
  35. Corrigendum to: Age appropriate reference intervals for eight kidney function and injury markers in infants, children and adolescents
  36. Letters to the Editor
  37. A panhaemocytometric approach to COVID-19: a retrospective study on the importance of monocyte and neutrophil population data on Sysmex XN-series analysers
  38. Letter in reply to the letter to the editor of Harte JV and Mykytiv V with the title “A panhaemocytometric approach to COVID-19: a retrospective study on the importance of monocyte and neutrophil population data”
  39. SARS-CoV-2 serologic tests: do not forget the good laboratory practice
  40. Long-term kinetics of anti-SARS-CoV-2 antibodies in a cohort of 197 hospitalized and non-hospitalized COVID-19 patients
  41. Self-sampling at home using volumetric absorptive microsampling: coupling analytical evaluation to volunteers’ perception in the context of a large scale study
  42. Vortex mixing to alleviate pseudothrombocytopenia in a blood specimen with platelet satellitism and platelet clumps
  43. Comparative evaluation of the fully automated HemosIL® AcuStar ADAMTS13 activity assay vs. ELISA: possible interference by autoantibodies different from anti ADAMTS-13
  44. Significant interference on specific point-of-care glucose measurements due to high dose of intravenous vitamin C therapy in critically ill patients
  45. As time goes by, on that you can rely … preservation of urine samples for morphological analysis of erythrocytes and casts
  46. Stability of control materials for α-thalassemia immunochromatographic strip test
  47. Reformulated Architect® cyclosporine CMIA assay: improved imprecision, worse comparability between methods
  48. Urine-to-plasma contamination mimicking acute kidney injury: small drops with major consequences
  49. Automated Mindray CL-1200i chemiluminescent assays of renin and aldosterone for the diagnosis of primary aldosteronism
  50. Use of common reference intervals does not necessarily allow inter-method numerical result trending
  51. Reply to Dr Hawkins regarding comparability of results for monitoring
Sign up now to receive a 20% welcome discount
Institutional Access
How does access work?
Have an idea on how to improve our website?
Please write us.
© 2025 De Gruyter Brill
Downloaded on 9.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2020-1296/pdf
Scroll to top button